341 related articles for article (PubMed ID: 8046653)
1. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
2. Reduction in nicotine intake and oral mucosal changes among users of Swedish oral moist snuff after switching to a low-nicotine product.
Andersson G; Axéll T; Curvall M
J Oral Pathol Med; 1995 Jul; 24(6):244-50. PubMed ID: 7562659
[TBL] [Abstract][Full Text] [Related]
3. The influence of cigarette consumption and smoking machine yields of tar and nicotine on the nicotine uptake and oral mucosal lesions in smokers.
Andersson G; Vala EK; Curvall M
J Oral Pathol Med; 1997 Mar; 26(3):117-23. PubMed ID: 9083935
[TBL] [Abstract][Full Text] [Related]
4. The Swedish snus and the Sudanese toombak: are they different?
Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
[TBL] [Abstract][Full Text] [Related]
5. Snus users had high levels of nicotine, cotinine and 3-hydroxycotinine in their breastmilk, and the clearance was slower than in smoking mothers.
Nordenstam F; Lundell B; Edstedt Bonamy AK; Raaschou P; Wickström R
Acta Paediatr; 2019 Jul; 108(7):1250-1255. PubMed ID: 30276861
[TBL] [Abstract][Full Text] [Related]
6. Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study.
Andersson G; Axéll T
J Oral Pathol Med; 1989 Jan; 18(1):2-7. PubMed ID: 2746515
[TBL] [Abstract][Full Text] [Related]
7. The influence of pH and nicotine concentration in oral moist snuff on mucosal changes and salivary pH in Swedish snuff users.
Andersson G; Warfvinge G
Swed Dent J; 2003; 27(2):67-75. PubMed ID: 12856395
[TBL] [Abstract][Full Text] [Related]
8. Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players.
Marclay F; Saugy M
J Chromatogr A; 2010 Nov; 1217(48):7528-38. PubMed ID: 20980010
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Nicotine and Cotinine in Plasma, Saliva, and Urine by HPLC Method in Chewing Tobacco Users.
Shaik FB; Nagajothi G; Swarnalatha K; Kumar CS; Maddu N
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3617-3623. PubMed ID: 31870102
[TBL] [Abstract][Full Text] [Related]
10. An in Vitro Study of Constituents Released from Smokeless Tobacco Products into Human Saliva.
Guan S; Bush L; Ji H
J Anal Toxicol; 2022 Jul; 46(6):625-632. PubMed ID: 34155520
[TBL] [Abstract][Full Text] [Related]
11. Validity of self reports in a cohort of Swedish adolescent smokers and smokeless tobacco (snus) users.
Post A; Gilljam H; Rosendahl I; Meurling L; Bremberg S; Galanti MR
Tob Control; 2005 Apr; 14(2):114-7. PubMed ID: 15791021
[TBL] [Abstract][Full Text] [Related]
12. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
Gray JN; Breland AB; Weaver M; Eissenberg T
Nicotine Tob Res; 2008 Sep; 10(9):1441-8. PubMed ID: 19023835
[TBL] [Abstract][Full Text] [Related]
13. Histologic changes associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study.
Andersson G; Axéll T; Larsson A
J Oral Pathol Med; 1989 Oct; 18(9):491-7. PubMed ID: 2481736
[TBL] [Abstract][Full Text] [Related]
14. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cotinine Is Positively Associated with Homocysteine in Smokers but Not in Users of Smokeless Tobacco.
Söderström E; Nilsson TK; Schneede J; Ueland PM; Midttun Ø; Gylling B; Johansson I; Hultdin J
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769882
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
[TBL] [Abstract][Full Text] [Related]
17. Oral mucosal changes related to smokeless tobacco usage: research findings in Scandinavia.
Axéll TE
Eur J Cancer B Oral Oncol; 1993 Oct; 29B(4):299-302. PubMed ID: 11706425
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of a reagent-impregnated test strip in identifying smokeless tobacco users.
Glover ED; Glover PN; Laflin MT; Nochur SV; Strnad JV
Nicotine Tob Res; 2007 Apr; 9(4):499-503. PubMed ID: 17454705
[TBL] [Abstract][Full Text] [Related]
19. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus).
Alizadehgharib S; Lehrkinder A; Alshabeeb A; Östberg AK; Lingström P
Eur J Oral Sci; 2022 Aug; 130(4):e12885. PubMed ID: 35853092
[TBL] [Abstract][Full Text] [Related]
20. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
